Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Microdosing may be suitable for individuals who: Have experienced intolerance to standard titration schedules Respond strongly to initial doses and wish to maintain results without escalation Prefer a preventive or maintenance strategy for weight stability Are new to GLP-1/GIP medications and want to monitor their tolerance Seek a more personalized approach under a clinicians supervision It is not recommended to alter dosing independentlyonly a qualified healthcare provider can determine whether a tirzepatide microdosing protocol is medically appropriate
According to a Morgan Stanley Research survey: 70% of the consumers indicated a significant or moderate change to eating behaviors eating more at home vs at restaurants, changing the choice of food when eating out and eating smaller meals
A study published in The New England Journal of Medicine in 2021 compared the effects of Tirzepatide and Semaglutide in obese individuals with type 2 diabetes
In general, rapid or unexplained weight shifts can signal that something is off and warrant evaluation from a clinician
Those who took semaglutide also experienced significant decreases in urinary albumin-to-creatinine ratio, a test that measures albumin in urine, and macroalbuminuria, a condition where the body excretes more than 300 milligrams of protein through urine daily
